Product
Losartan + HCTZ
1 clinical trial
1 indication
Indication
HypertensionClinical trial
An Open-label, Single Arm, Prospective Study to Evaluate the Safety and Anti-hypertensive Efficacy of Losartan 50 mg / Hydrochlorothiazide (HCTZ) 12.5 mg Combination in Patients With Mild to Moderate Essential HypertensionStatus: Completed, Estimated PCD: 2009-06-01